BATON ROUGE, La. (WAFB) - Atrial Fibrillation, or AFib is the leading cause of stroke. The American Heart Association says five million Americans currently have AFib, with an additional 12 million ...
DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
SAN FRANCISCO -- Two mainstream devices for percutaneous left atrial appendage (LAA) closure continued to lead to similar clinical outcomes in the SWISS-APERO trial. Among patients randomized to the ...
The Watchman device manufacturer estimates the out-of-pocket cost of having Watchman surgery to be $2,607 in 2024. This out-of-pocket estimate would include your Medicare Part A deductible, which is ...
More special care is needed when using the Watchman access systems used to deliver transcatheter left atrial appendage (LAA) closure devices due to a risk for air embolisms, according to an FDA alert.
(Updated) SAN FRANCISCO, California — Preliminary data from the PREVAIL study of the Watchman (AtriTech/Boston Scientific) device for the prevention of stroke and systemic embolism in patients with ...
Use of two high-risk cardiovascular devices—the Watchman (Boston Scientific) left atrial appendage occluder and the Impella (Abiomed) left ventricular assist device—is highest in the United States ...
Boston Scientific is recommending updates to the instructions for use (IFU) for certain access systems for its Watchman FLX left atrial appendage occlusion (LAAO) device to help mitigate the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback